ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

RPRX Royalty Pharma PLC

27.41
1.03 (3.90%)
2024年6月1日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Royalty Pharma PLC RPRX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
1.03 3.90% 27.41 05:06:12
始値 安値 高値 終値 前日終値
26.50 26.45 27.49 27.41 26.38
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/3006:25EDGAR2Form 8-K - Current report
2024/5/2820:10GLOBERoyalty Pharma and Agios Pharmaceuticals Enter Into..
2024/5/2305:10GLOBERoyalty Pharma and Cytokinetics Announce Expanded Strategic..
2024/5/2305:00GLOBECytokinetics and Royalty Pharma Announce Expanded Strategic..
2024/5/1706:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1321:15GLOBERoyalty Pharma to Present at Upcoming Investor Conferences
2024/5/0922:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0920:17EDGAR2Form 8-K - Current report
2024/5/0920:00GLOBERoyalty Pharma Reports First Quarter 2024 Results
2024/5/0919:45GLOBERoyalty Pharma to Acquire Royalty Interest in Sanofi’s..
2024/4/1921:15GLOBERoyalty Pharma to Announce First Quarter 2024 Financial..
2024/4/1721:15GLOBERoyalty Pharma Declares Second Quarter 2024 Dividend
2024/2/2906:15GLOBERoyalty Pharma to Present at TD Cowen’s 44th Annual Health..
2024/2/1523:05EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/2/1521:33EDGAR2Form 8-K - Current report
2024/2/1521:30GLOBERoyalty Pharma Reports Q4 and Full Year 2023 Results
2024/2/0621:01EDGAR2Form 8-K - Current report
2024/1/3106:15GLOBERoyalty Pharma To Announce Fourth Quarter And Full Year 2023..
2024/1/1922:15GLOBERoyalty Pharma Announces Dividend Increase
2024/1/0821:18EDGAR2Form 8-K - Current report
2024/1/0821:00GLOBERoyalty Pharma Highlights Accomplishments and Provides..
2024/1/0406:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:30EDGAR2Form 144 - Report of proposed sale of securities
2023/12/3006:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2806:31EDGAR2Form 8-K - Current report
2023/12/2803:05EDGAR2Form 8-K - Current report
2023/12/2006:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1606:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/1406:47EDGAR2Form 144 - Report of proposed sale of securities
2023/11/2806:15GLOBERoyalty Pharma to Present at the Evercore ISI 6th Annual..
2023/11/1707:16EDGAR2Form 8-K - Current report
2023/11/1707:13EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/11/1509:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1322:10GLOBERoyalty Pharma and Teva Collaborate to Further Accelerate..
2023/11/1322:00BWTeva and Royalty Pharma Collaborate to Further Accelerate..
2023/11/0823:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0821:40EDGAR2Form 8-K - Current report
2023/11/0821:00GLOBERoyalty Pharma Reports Third Quarter 2023 Results
2023/10/1922:29EDGAR2Form 8-K - Current report
2023/10/1920:59GLOBERoyalty Pharma Announces Agreement to Purchase Up to $1.5..
2023/10/1705:15GLOBERoyalty Pharma Declares Fourth Quarter 2023 Dividend
2023/10/1205:15GLOBERoyalty Pharma To Announce Third Quarter 2023 Financial..
2023/10/0405:15EDGAR2Form 144 - Report of proposed sale of securities
2023/10/0405:15EDGAR2Form 144 - Report of proposed sale of securities
2023/9/2121:25GLOBERoyalty Pharma Appoints Eric Schneider as Chief Technology..
2023/9/0605:15GLOBERoyalty Pharma and Ascendis Pharma Enter Into $150 Million..
2023/9/0605:01GLOBEAscendis Pharma and Royalty Pharma Enter into $150 Million..
2023/9/0521:25GLOBERoyalty Pharma to Present at Upcoming Investor Conferences
2023/8/2419:30GLOBERoyalty Pharma and Ferring Pharmaceuticals Enter Into US..
2023/8/2414:15BWRoyalty Pharma and Ferring Pharmaceuticals Enter into US..

最近閲覧した銘柄

Delayed Upgrade Clock